ºÚÁÏÕýÄÜÁ¿

The Honorable Jay Obernolte 2433 Rayburn House Office Building Washington, D.C. 20515	The Honorable Haley Stevens 2411 Rayburn House Office Building Washington, D.C. 20515
The Honorable Todd Young 185 Dirksen Senate Office Building Washington, D.C. 20510	The Honorable Chris Coons 218 Russell Senate Office Building Washington, D.C. 20510

Dear Representatives Obernolte and Stevens and Senators Young and Coons:

On behalf of the ºÚÁÏÕýÄÜÁ¿, which represents over 37,000 scientists dedicated to advancing the microbial sciences, we thank you for introducing the Expanding Partnerships for Innovation and Competitiveness (EPIC) Act. 

The National Institute of Standards and Technology (NIST) plays a critical role in advancing biotechnology, improving our understanding of the microbiome and strengthening national preparedness against emerging infectious diseases. From providing reference materials that enable the rapid development of diagnostic tests for emerging pathogens, to releasing the first-ever fecal microbiome reference material to accelerate lifesaving treatments, NIST’s work is essential to microbiologists and the broader scientific community. Its standards and guidance also ensure the reproducibility and safety of scientific research across disciplines.

Partnerships and research infrastructure improvements are vital for NIST to keep pace with rapid developments in biotechnology, supporting U.S. leadership in the bioeconomy. ºÚÁÏÕýÄÜÁ¿supports this important legislation that will lead to the development of new technologies and innovation and urges swift congressional action. If you have any questions, please contact Nick Cox, Senior Federal Affairs Officer, at ncox@asmusa.org.

Sincerely,



Amalia Corby
Director of Federal Affairs
ºÚÁÏÕýÄÜÁ¿